Notes / Company

Genomic Valley Biotech Ltd.

GVBL BSE 539206 ISIN INE574D01010 Agriculture

Fundamentals

Market cap: ₹8.11 cr
ROE: 9.13%
Debt / equity: 0.00
52-week range: 20.10 — 54.27

The timeline — 1 note on Genomic Valley Biotech Ltd.

May 2026

29 May 26 · 7:24 PM IST Brief

Brief · Earnings · Micro cap

Genomic Valley Biotech profit shrinks 91% as revenue halves

The biotech's annual revenue fell to ₹26.75 lakhs, while net profit collapsed to ₹3.03 lakhs.

Verify on exchange BSE filings for GVBL NSE filings for GVBL